The major surface glycoprotein of Pneumocystis carinii induces release and gene expression of interleukin-8 and tumor necrosis factor alpha in monocytes

Infection and Immunity

Volumn 65, Issue 11, 1997, Pages 4790-4794

  Benfield, Thomas L ^a   Lundgren, Bettina ^a   Levine, Stewart J ^b   Kronborg, Gitte ^a   Shelhamer, James H ^b   Lundgren, Jens D ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL ISOLATION; CHEMOTAXIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0030784502     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.11.4790-4794.1997     Document Type: Article

References (43)

1. Adams, D. H., and S. Shaw. 1994. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 343:831-836.
2. Agostini, C., R. Zambello, L. Trentin, S. Garbisa, P. F. Di Celle, P. Bulian. M. Onisto, V. Poletti. L. Spiga. E. Raise. R. Foà. and G. Semenzato. 1991 Alvcolar macrophages from patients with AIDS and AIDS-related complex constitutively synthesize and release tumor necrosis factor alpha. Am. Rev. Respir. Dis. 144:195-201.
3. Bendtsen, K. D., T. L. Nielsen, J. M. E. Schattenkerk, B. N. Jensen. and J. D. Lundgren. 1993. Type 111 procollagen in serum as marker of disease activity and prognosis in patients with Pneumocystis carinii infection. Am. Rev. Respir. Dis. 148:490-494.
4. Benfield, T. L., P. Prentø, J. Junge, J. Vestbo, and J. D. Lundgren. Alveolar damage m AIDS-associatcd Pneumocystis carinii pneumonia. Chest, in press.
5. Benfield, T. L., J. K. Schattenkerk, B. Hofmann, B. N. Jensen, T. L. Nielsen, and J. D. Lundgren. 1944. Differential effect on serum neoplerin and serum beta 2-microglobulin is induced by treatment in Pneumocystis carinii pneumonia. J. Infect. Dis. 169:1170-1173.
6. Benfield, T. L., K. van Steenwijk, T. L. Nielsen, J. K. Dichter, G. Y. Lipschik, B. N. Jensen, J. Junge, J. H. Shelhamer, and J. D. Lundgren. 1995. Interleukin-8 and eicosanoid production in the lung during moderate to severe Pneumocystis carinii pneumonia in AIDS: a role of interleukin-8 in the pathogenesis of P. carinii pneumonia. Respir. Med. 89:285-290.
7. Benfield, T. L., J. Vestbo, J. Junge, T. L. Nielsen, A. B. Jensen, and J. D. Lundgren. 1995. Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am. J. Respir. Crit. Care Med. 151:1058-1062.
8. Böyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Lab. Invest. 21:77.
9. Chen, W., K. A. Hawell, and A. G. Harmsen. 1992. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect. Immun. 60:1279-1284.
10. Djeu, J. Y., K. Matsushima, J. J. Oppenheim, K. Shiotsuki, and D. K. Blanchard. 1990. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. J. Immunol. 144: 2205-2210.
11. Ezekowitz, R. A. B., U. J. Williams, H. Koziel, M. Y. K. Armstrong, A. Warner, F. F. Richards, and R. M. Rose. 1991. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 351:155-158.
12. Fekade, D., K. Knox, K. Hussein, A. Melka, D. G. Lalloo, R. E. Coxon, and D. A. Warrell. 1996. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor α. N. Engl. J. Med. 335:311-315.
13. Gigliotti, F., P. J. Haidaris, C. G. Haidaris, T. W. Wright, and K. R. Van der Meid. 1993. Further evidence of host species-specific variation in antigens of Pneumocystis carinii using the polymerase chain reaction. J. Infect. Dis. 168:191-194.
14. Hoffman, O. A., J. E. Standing, and A. H. Limper. 1993. Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. J. Immunol. 150:3932-3940.
15. Israël-Biet, D., J. Cadranel, K. Beldjord, J. Andrieu, A. Jeffrey, and P. Even. 1991. Tumor necrosis factor production in HIV-seropositive subjects. J. Immunol. 147:490-494.
16. Kandil, O., J. A. Fishman, H. Koziel, P. Pinkston, R. M. Rose, and H. G. Remold. 1994. Human immunodeficiency virus type 1 infection of human macrophages modulates the cytokine response to Pneumocystis carinii. Infect. Immun. 62:644-650.
17. Kolls, J. K., J. M. Beck, S. Nelson, W. R. Summer, and J. Shellito. 1993. Alveolar macrophage release of tumor necrosis factor during murine Pneumocystis carinii pneumonia. Am. J. Respir. Cell Mol. Biol. 8:370-376.
18. Kolls, J. K., D. Lei, C. Vasquez, G. Odom, W. R. Summer, S. Nelson, and J. Shellito. 1997. Exacerbation of murine Pneumocystis carinii infection by adenoviral-mediated gene transfer of a TNF inhibitor. Am. J. Respir. Cell Mol. Biol. 16:112-118.
19. Kovacs, J. A., J. L. Halpern, J. C. Swan, J. Moss, J. E. Parillo, and H. Masur. 1988. Identification of antigens and antibodies specific for Pneumocystis carinii. J. Immunol. 140:2023-2031.
20. Krishnan, V. L., A. Meager, D. M. Mitchell, and A. J. Pinching. 1990. Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor-alpha production in Pneumocystis carinii pneumonia. Clin. Exp. Immunol. 80:156-160.
21. Kronborg, G., A. Fomsgaard, G. H. Shand, S. Lanng, M. B. Hansen, T. Pressler, and N. Høiby. 1992. TNF-α and immune complexes in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection. Immunol. Infect. Dis. 2:171-177.
22. Larsen, C. G., A. O. Anderson, E. Appela, J. J. Oppenheim, and K. Matsushima. 1989. The neutrophil-activating protein (NAP-1) is also ehemotactic for T lymphocytes. Science 243:1464-1466.
23. Leonard, K. J., and T. Yoshimura. 1990. Neutrophil attractant activation protein-1 (NAP-1 |interleukin-8|). Am. J. Respir. Cell Mol. Biol. 2:479-486.
24. Limper, A. H., K. P. Offord, T. F. Smith, and W. J. Martin. 1989. Pncumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am. Rev. Respir. Dis. 140:1204-1209.
25. Limper, A. H., J. E. Standing, O. A. Hoffman, M. Castro, and L. W. Neese. 1993. Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells. Infect. Immun. 61:4302-4309.
26. Linke, M. J., M. T. Cushion, and P. O. Walzer. 1989. Properties of the major antigens of rat and human Pneumocystis carinii. Infect. Immun. 57:1547-1555.
27. Lipschik, G. Y., M. E. Doerfler, J. A. Kovacs, W. D. Travis, V. A. Andrawis. M. G. Lawrence, J. R. Dichter, F. P. Ognibene, and J. H. Shelhamer. 1943 Leukotriene B4 and interleukin-8 in human immunodeficiency virus-related pulmonary disease. Chest 104:763-769.
28. Lundgren, B., G. Y. Lipschik, and J. A. Kovacs. 1991. Purification and characterization of a major human Pneumocystis carinii surface antigen. J. Clin. Invest. 87:163-170.
29. Lundgren, J. D., S. K. Barton, C. Katlama, B. Ledergerber, J. Gonzales-Lahoz, A. J. Pinching, R. Proenca, K. Hemmer, C. Pedersen, and A. N. Phillips. 1995. Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for 2533 European patients with acquired immunodeficiency syndrome. AIDS in Europe Study Group. Arch. Intern. Med. 155:822-828.
30. Masur, H. 1992. Prevention and treatment of Pneumocystis pneumonia. N. Engl. J. Med. 327:1853-1860.
31. Masur, H., and T. C. Jones. 1978. The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J. Exp. Med. 147:157-170.
32. Masur, H., P. Meier, and J. A. McCutchan. 1990. Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. N. Engl. J. Med. 323:1500-1504.
33. O'Riordan, D. M., J. E. Standing, K. Y. Kwon, D. Chang, E. C. Crouch, and A. H. Limper. 1995. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J. Clin. Invest. 95:2699-2710.
34. Ptveri, P., A. Walz, B. Dewald, and M. Baggiolini. 1988. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J. Exp. Med. 167:1547-1559.
35. Pottratz, S. T., and W. J. Martin II. 1990. Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells. J. Clin. Invest. 85:351-356.
36. Pottratz, S. T., J. Paulsrud, J. S. Smith, and W. J. Martin II. 1991. Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein. J. Clin. Invest. 88:403-407.
37. Rayment, N., K. F. Miller, N. Ali, M. H. Binks, and U. R. Katz. 1996 Synthesis of tumor necrosis factor-alpha mRNA in bronchoalveolar lavage cells from human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia. J. Infect. Dis. 174:654-659.
38. Skøt, J., P. Kabrit, J. E. Hansen, J. O. Nielsen, L. Nielsen, and J. D. Lundgren. 1994. Tumour necrosis factor and eicosanoid production from monocytes exposed to HIV in vitro. APMIS 102:603-611.
39. Theus, S. A., M. J. Linke, R. P. Andrews, and P. D. Walzer. 1993. Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii. Infect. Immun. 61:4703-4709.
40. Vestbo, J., T. L. Nielsen, J. Junge, and J. D. Lundgren. 1993. Amount of Pneumocystis carinii and degree of acute lung inflammation in HIV-associated P. carinii pneumonia. Chest 104:109-113.
41. Vilcek, J., and T. H. Lee. 1991. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 266:7313-7316.
42. Von Behren, L. A., and E. L. Pesanti. 1978 Uptake and degradation of Pneumocystis carinii by macrophages in vitro. Am. Rev. Respir. Dis. 118: 1051-1059.
43. Yoshimura, T., and D. G. Johnson. 1993 cDNA cloning and expression of guinea pig neutrophil attractant protein-1 (NAP-1). J. Immunol. 151:6225-6236.